Personal information

No personal information available

Activities

Collapse all

Works (8)

Incidence and potential risk factors of human cytomegalovirus infection in patients with severe and critical coronavirus disease 2019

Journal of Infection and Chemotherapy
2025-01 | Journal article
DOI: 10.1016/j.jiac.2024.06.015
Contributors: Waki Imoto; Takumi Imai; Ryota Kawai; Yasutaka Ihara; Yuta Nonomiya; Hiroki Namikawa; Koichi Yamada; Hisako Yoshida; Yukihiro Kaneko; Ayumi Shintani et al.
Source: check_circle
Crossref

Evaluation of predictors of third-generation cephalosporin non-susceptibility and factors affecting recurrence or death in bacteremia caused by Citrobacter freundii complex , Enterobacter cloacae complex, and Klebsiella aerogenes

Journal of Chemotherapy
2024-10-02 | Journal article
DOI: 10.1080/1120009X.2024.2323326
Contributors: Kazuhiro Kobayashi; Atsuko Hata; Waki Imoto; Shigeki Kakuno; Wataru Shibata; Koichi Yamada; Hiroshi Kawaguchi; Norihiro Sakurai; Toshikazu Ito; Kazuya Uenoyama et al.
Source: check_circle
Crossref

Impact of antimicrobial stewardship with the Xpert MRSA/SA BC assay at a tertiary hospital in Japan

Journal of Infection and Chemotherapy
2023-07 | Journal article
DOI: 10.1016/j.jiac.2023.03.021
Contributors: Koichi Yamada; Waki Imoto; Wataru Shibata; Shigeki Kakuno; Kiyotaka Nakaie; Yuka Myodo; Naomi Takayama; Akane Dobashi; Minami Imai; Kei Mitani et al.
Source: check_circle
Crossref

Characterization of Aspergillus spp. isolated from patients with coronavirus disease 2019

Journal of Infection and Chemotherapy
2023-06 | Journal article
DOI: 10.1016/j.jiac.2023.02.001
Contributors: Masashi Ogawa; Makoto Niki; Waki Imoto; Akane Dobashi; Minami Imai; Naomi Takayama; Kei Mitani; Shigeki Kakuno; Wataru Shibata; Koichi Yamada et al.
Source: check_circle
Crossref

COVID-19 vaccination benefits in preventing severe disease in mild-to-moderate cases: An analysis in the first specialized hospital for COVID-19 in Japan

Respiratory Investigation
2023-03 | Journal article
DOI: 10.1016/j.resinv.2022.12.011
Contributors: Masanori Kobayashi; Atsushi Miyamoto; Tetsuya Watanabe; Kenji Sawa; Kanako Sato; Kazuhiro Yamada; Naoko Yoshii; Koichi Yamada; Kengo Kawamoto; Masato Uji et al.
Source: check_circle
Crossref

Siderophore production as a biomarker for Klebsiella pneumoniae strains that cause sepsis: A pilot study

Journal of the Formosan Medical Association
2022-04 | Journal article
DOI: 10.1016/j.jfma.2021.06.027
Contributors: Hiroki Namikawa; Makoto Niki; Mamiko Niki; Ken-Ichi Oinuma; Koichi Yamada; Kiyotaka Nakaie; Taishi Tsubouchi; Yoshihiro Tochino; Yasuhiko Takemoto; Yukihiro Kaneko et al.
Source: check_circle
Crossref

Clinical usefulness of very high serum soluble interleukin-2 receptor levels for the detection of tuberculous peritonitis in a patient with chronic myelogenous leukemia

Journal of Infection and Chemotherapy
2020-10 | Journal article
DOI: 10.1016/j.jiac.2020.05.001
Contributors: Makoto Moriguchi; Hideo Koh; Tetsuya Hayashi; Hiroshi Okamura; Satoru Nanno; Yasuhiro Nakashima; Takahiko Nakane; Waki Imoto; Koichi Yamada; Hiroshi Kakeya et al.
Source: check_circle
Crossref

The intervention by an antimicrobial stewardship team can improve clinical and microbiological outcomes of resistant gram-negative bacteria

Journal of Infection and Chemotherapy
2019-12 | Journal article
DOI: 10.1016/j.jiac.2019.05.026
Contributors: Koichi Yamada; Waki Imoto; Kazushi Yamairi; Wataru Shibata; Hiroki Namikawa; Naoko Yoshii; Hiroki Fujimoto; Kiyotaka Nakaie; Yasuyo Okada; Akiko Fujita et al.
Source: check_circle
Crossref
How many people are using ORCID?